Int. J. Mol. Sci. 2013, 14(6), 10710-10726; doi:10.3390/ijms140610710
Article

Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles

Reference and Translation Center for Cardiac Stem Cell Therapy (RTC), Department of Cardiac Surgery, University of Rostock, Schillingallee 35, 18057 Rostock, Germany
* Author to whom correspondence should be addressed.
Received: 27 March 2013; in revised form: 29 April 2013 / Accepted: 3 May 2013 / Published: 23 May 2013
(This article belongs to the Special Issue Magnetic Nanoparticles 2013)
PDF Full-text Download PDF Full-Text [2634 KB, uploaded 23 May 2013 11:52 CEST]
Abstract: Bone marrow derived human mesenchymal stem cells (hMSCs) show promising potential in regeneration of defective tissue. Recently, gene silencing strategies using microRNAs (miR) emerged with the aim to expand the therapeutic potential of hMSCs. However, researchers are still searching for effective miR delivery methods for clinical applications. Therefore, we aimed to develop a technique to efficiently deliver miR into hMSCs with the help of a magnetic non-viral vector based on cationic polymer polyethylenimine (PEI) bound to iron oxide magnetic nanoparticles (MNP). We tested different magnetic complex compositions and determined uptake efficiency and cytotoxicity by flow cytometry. Additionally, we monitored the release, processing and functionality of delivered miR-335 with confocal laser scanning microscopy, real-time PCR and live cell imaging, respectively. On this basis, we established parameters for construction of magnetic non-viral vectors with optimized uptake efficiency (~75%) and moderate cytotoxicity in hMSCs. Furthermore, we observed a better transfection performance of magnetic complexes compared to PEI complexes 72 h after transfection. We conclude that MNP-mediated transfection provides a long term effect beneficial for successful genetic modification of stem cells. Hence, our findings may become of great importance for future in vivo applications.
Keywords: magnetic nanoparticles; microRNA; polyethylenimine; mesenchymal stem cells; non-viral carrier

Supplementary Files

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Schade, A.; Delyagina, E.; Scharfenberg, D.; Skorska, A.; Lux, C.; David, R.; Steinhoff, G. Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles. Int. J. Mol. Sci. 2013, 14, 10710-10726.

AMA Style

Schade A, Delyagina E, Scharfenberg D, Skorska A, Lux C, David R, Steinhoff G. Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles. International Journal of Molecular Sciences. 2013; 14(6):10710-10726.

Chicago/Turabian Style

Schade, Anna; Delyagina, Evgenya; Scharfenberg, Dorothee; Skorska, Anna; Lux, Cornelia; David, Robert; Steinhoff, Gustav. 2013. "Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles." Int. J. Mol. Sci. 14, no. 6: 10710-10726.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert